Os Therapies Incorporated OSTX

$1.55 +0.06 (4.03%)

Valuation

Market cap
68,728,000
Revenue TTM
$0
Net income TTM
$-28,750,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
586,700
Avg volume
631,402
Day's range
$1.46 – $1.57
Shares out
46,126,000
Stochastic %K
31%
Beta
-0.64
Analysts
Strong Sell
Price target
$8.50

Price

Company profile

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company's pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technol...

Show more

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company's pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. The company was incorporated in 2018 and is based in Grasonville, Maryland.

Industry
Biotechnology
Sector
Healthcare
Phone
410 297 7793
Website
https://ostherapies.com
Address
115 Pullman Crossing Road, Suite 103, Grasonville, United States

Latest news

Stocktwits

Think2c Oct 8, 2:30 PM
$OSTX lower volume trading(or actually return to baseline volume), continues to support the thesis that a large ATM sale of shares to raise cash was behind the PR day drop in share price. Hopefully those in for the long-term used the opportunity to buy more as I did. I expect a trend upward with some de risking from the last PR and ongoing PRs over the next couple weeks will help. Especially if and when there is an announcement that phase 3 study has started.
1 replies
SellasgpsCurativeBAT11 Oct 8, 2:18 PM
$ICU $OSTX $SLS OSTX just stepped in big leagues now. A major deal coming here. Timing Everything to Perfection. AMERICA'S BEST PR AGENCY - FORBES, 2021 Rubenstein Public Relations is honored to have been recognized in Forbes' list of America's Best PR Agencies for 2021. This recognition comes in partnership with Statista, following a comprehensive evaluation involving more than 12,700 experts and 20,500 customers who nominated over 5,000 firms. The evaluation highlighted our firm's ability to diversify offerings beyond traditional PR tactics, embracing roles akin to consulting and advertising firms, and incorporating data-driven insights and research to enhance both external and internal communications. This award reflects our proactive approach during a challenging year, further establishing us as a leader in the dynamic field of public relations. ✌️🙏❤️‍🩹
1 replies
SellasgpsCurativeBAT11 Oct 8, 2:12 PM
$OSTX $SLS $ICU OSTX making all the right moves. Rubenstein Public Relations Named Agency of Record for OS Therapies 10/8/2026 6:22am NEW YORK, Oct. 08, 2026 (GLOBE NEWSWIRE) --Rubenstein Public Relations (RPR), a leading full-service communications firm, announces it has been named the Agency of Record for OS Therapies, Inc. (NYSE American: OST), the world leader in gene-edited, Listeria-based cancer immunotherapies. Recently, OS Therapies announced that it has reached a critical point in achieving entry into the global market with access into the U.K national patient registry and UK Clinical Practice Research Datalink (CPRD) by the U.K. Medicines and Healthcare products Regulatory Agency (MHRA). This comes after OS Therapies was accepted into the US Food and Drug Administration's (FDA) Project Orbis, where 29 MHRA-led oncology products have been approved. ✌️🙏❤️‍🩹
1 replies
DrRivington Oct 8, 1:52 PM
$OSTX nice lift up from the open!
2 replies
TeaBaggerVance Oct 8, 1:33 PM
$OSTX Just named a global PR firm as the agency of record.
1 replies
cwork Oct 8, 12:59 AM
$OSTX PRV sold today for $210M! https://ir.ultragenyx.com/news-releases/news-release-details/ultragenyx-enters-agreement-sell-rare-pediatric-disease-priority
3 replies
SellasgpsCurativeBAT11 Oct 7, 11:51 PM
$ICU $OSTX $PDSB ICU Shorts are going to ICU by Friday $5.00+ ✌️🙏❤️‍🩹
1 replies
Juhanialainen Oct 7, 7:12 PM
$CAPR GET IN! $IBRX $OSTX $PDSB
1 replies